The largest community of pharma leaders

F-star Appoints Darlene Deptula-Hicks as Chief Financial Officer and Opens Office in Cambridge, MA

CAMBRIDGE, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–F-star Therapeutics Ltd., a clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy, today announces the appointment of Darlene Deptula-Hicks, MBA as Chief Financial Officer (CFO), succeeding Tolga Hassan, who is appointed to serve as F-star’s Chief Operating Officer. Darlene Deptula-Hicks joins F-star from Northern Biologics, Inc., a clinical-stage biotechnology company…

 

 

 

http://www.businesswire.com/news/home/20190618005498/en/F-star-Appoints-Darlene-Deptula-Hicks-Chief-Financial-Officer/

Recent Articles

Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®

MONTREAL & BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD and Knight announces approval of...

Global DNA Sequencing Technologies, Markets & Companies Report 2020: Market Value for 2019 & Estimates for 2024 & 2029 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "DNA Sequencing - Technologies, Markets & Companies" report from...

Seattle Genetics and Genmab Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020

BOTHELL, Wash. & COPENHAGEN, Denmark--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) and Genmab...

Heart Valve Voice US to Train Patients As Research Advisors and Advocates

WASHINGTON--(BUSINESS WIRE)--Heart Valve Voice US—a patient-advocacy organization focused on improving the...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.